Risks and results of surgery
In deciding which United Kingdom hospitals in the new internal market of the National Health Service should get the contracts, and hence which institutions should be able to survive, the obvious solution (which has been suggested) is to look at the rate of survival of their patients. What could be simpler than publicising mortality figures and let market forces do the rest? Such league tables have been mooted. They started 8 years ago in the United States when the results of open heart surgery in hospitals providing Medicare were made public. ' The immediately obvious problem is that league tables assume that all hospitals are taking on cases of similar risk. They then reward low risk, however it is achieved. We know that the lowest risk is obtained in patients for whom the indications for operation are least pressing. grafting.
This method was tested in British practice by Nashef and colleagues in Manchester.2 They confirmed that the system discriminated very well between these groups. The actual mortality figures in each stratum were consistently less than predicted by Parsonnet scores but the 95% confidence intervals of the proportions always included the predicted risk. In our own work we have found the same. The elements of the risk stratification are entered into our database before or at the time of operation. We have used Parsonnet data to compare the case mix of different surgeons within the unit3 and to monitor the risk of cases delegated to trainees.4 In all instances we have found, as did Nashef et al, that the actual mortalities in the groups ascend in step with the risk strata, but that we consistently achieve lower than predicted mortality in each group. Our conclusion is that this does not invalidate Parsonnet: it reflects the fact that we are comparing our present work (in a unit that has every intention of being in the 50% with "above average results") with figures that were achieved a decade ago.
Nashef et al wrote "Some surgeons and cardiologists are dismayed that the system excludes their 'favourite' risk factors: unstable angina, lung disease, and severity of coronary lesions are conspicuously absent but are difficult to define (unstable angina), not always documented (lung disease), or both (severity of coronary lesions). It is because such factors are excluded that the Parsonnet system is objective and easy to implement." I agree with that appraisal. There are always some who point to the case in which the prediction failed and the case that beat the odds or they claim that their clinical judgement is better than statistics. Let them hold those views. For our working purposes, Parsonnet is simple to use, robust, and useful for making informed comparisons between groups, and can always be overridden in the management of individuals.
More substantial was Spiegelhalter's criticism.5 Pointing to the consistent overestimate of risk, he faulted the use of univariate analysis and an additive model. As it stands, the predicted risks are too high and simply doing as well as them might not be doing as well as we should in the mid 1990s. The challenge is to refine the model and recalibrate it. However, Parsonnet scoring is not intended to be a crystal ball, gazed into to predict the outcome for an individual. The individual will be alive or dead, a hard fact disguised by some operational phrase such as "dichomotous actual outcome state". The purpose of scoring systems in this instance is to provide a means of redressing apparent differences in results by correcting for differential case mix. 
